AIP
AVEO

Ameritas Investment Partners’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Ameritas Investment Partners’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,842
Closed -$13K – 3368
2021
Q1 		$13K Buy
1,842
+640
+53% +$5.52K ﹤0.01% 2763
2020
Q4 		$7K Hold
1,202
– – ﹤0.01% 2928
2020
Q3 		$7K Hold
1,202
– – ﹤0.01% 2906
2020
Q2 		$6K Buy
+1,202
New +$7.59K ﹤0.01% 2940
2019
Q2 		– Sell
-817
Closed -$7K – 3162
2019
Q1 		$7K Hold
817
– – ﹤0.01% 2816
2018
Q4 		$13K Hold
817
– – ﹤0.01% 2580
2018
Q3 		$27K Hold
817
– – ﹤0.01% 2369
2018
Q2 		$18K Buy
+817
New +$19.4K ﹤0.01% 2583

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameritas Investment Partners's AVEO Position: Q2 2021 in Review

Ameritas Investment Partners sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q2 2021, closing a stake of 1,842 shares — an estimated $13K sold.

Ameritas Investment Partners first reported a position in AVEO in Q2 2018 and held it in 8 quarters. The position peaked at $27K in Q3 2018. 63 funds tracked by Wall St. Rank hold AVEO as of Q2 2021.

  • Ameritas Investment Partners reported no remaining AVEO Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Partners sold 1,842 AVEO Pharmaceuticals, Inc. shares in Q2 2021, an estimated $13K.
  • Ameritas Investment Partners first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 8 quarters.
  • Ameritas Investment Partners's AVEO Pharmaceuticals, Inc. position peaked at $27K in Q3 2018.
  • 63 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q2 2021.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.